Perran Fulden Yumuk
Koç University · 252 works · 5,691 citations · h-index 21
Top works
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study
- Extrapulmonary Small Cell Carcinoma: Multimodality Treatment Results
- Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival
- What is the Optimal Number of Lymph Nodes to be Dissected in Colorectal Cancer Surgery?
- HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples.
- Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer
- Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy
- Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
- Port Needles
- Chordoma: a case series and review of the literature
- Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer
- Epithelioid hemangioendothelioma with multiple organ involvement
- Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients
- A rare case of primary rectal choriocarcinoma and review of the literature
- Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
- Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis
- Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature
- Newly diagnosed breast cancer in a patient receiving imatinib mesylate